Abstract

The number of patients undergoing transcatheter aortic valve implantation (TAVI) with the potential for re-intervention is steadily increasing; however, there is a risk of sinus sequestration (SS) during a redo TAVI. The prevalence, predictors, and risk stratification of risk for SS remain uncertain. We analyzed computed tomography acquired from 263 patients who underwent TAVI between 2021 and 2022: balloon-expandable valve (BEV), 71%, and self-expandable valve (SEV), 29%. Patients were considered at risk of SS if they met 1) BEV frame > sino-tubular junction (STJ) or SEV neo-commissure > STJ and 2) valve-to-STJ < 2 mm. The risk of left, right, and any SS in 51%, 50%, and 65%, respectively, which did not differ between BEV and SEV. The predictors of any SS were the height of the left and right coronary cusp (Odds ratio [OR], 0.81 and 0.71; cut-off, 18.6 and 19.2 mm) and STJ minus annulus diameter (OR, 0.65; cut-off, 3.7 mm) in BEV, and STJ diameter (OR, 0.47; cut-off, 27.6 mm) in SEV. The number of predictors stratified the risk of any SS: low risk with BEV, at 0 predictors (14% at risk of SS); intermediate risk, 1 predictor (65%); high risk, 2 or 3 predictors (81% and 95%); low risk with SEV, 0 predictors (33%), vs. high risk, 1 predictor (91%). In conclusion, two-thirds of patients undergoing TAVI were at risk of SS. The height of the coronary cusp and the STJ diameter were associated with, and adequately stratified the risk of SS.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.